Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

130.59 +1.33 (+1.03%)

Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

50 51 Next >

(ABT) - Analyzing Abbott Laboratories's Short Interest ↗

May 16, 2023

Via Benzinga

Claims of PediaSure Boosting Children's Height Challenged in Lawsuit Against Abbott Laboratories ↗

May 16, 2023

A New York City woman has reportedly sued Abbott Laboratories (NYSE: ABT), accusing them of misleading consumers into believing its PediaSure nutrition drinks were "clinically proven" to increase...

Via Benzinga

A Look Into Abbott Laboratories Inc's Price Over Earnings ↗

May 15, 2023

Via Benzinga

Investing for the Long-Term? Here are 7 Must-Have Dividend Stocks ↗

May 14, 2023

Here are seven must-have dividend stocks for long-term investing that you can consider for your dividend stock portfolio.

Via InvestorPlace

Abbott Laboratories Unusual Options Activity For May 10 ↗

May 10, 2023

Via Benzinga

Cramer Asks Investors To Focus On Individual Stocks Over Macro Strategies: Says Don't 'Miss The Trees For The Forest' ↗

May 09, 2023

Via Benzinga

Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years ↗

May 05, 2023

Via Benzinga

Looking At Abbott Laboratories's Recent Unusual Options Activity ↗

April 28, 2023

Via Benzinga

Got $1,000? 2 Top Dividend Stocks to Buy Now ↗

April 28, 2023

Passive income can add to your stock market winnings.

Via The Motley Fool

3 Dividend Stock Warning Signs That Could Portend Trouble ↗

May 06, 2023

Recognizing these red flags will help you avoid investing in weaker businesses.

Via The Motley Fool

Is Dexcom a Good Stock to Buy Now? ↗

May 02, 2023

A poorly received first-quarter earnings report has investors wondering if this stock's best days are behind it.

Via The Motley Fool

3 Stocks to Buy Before They Soar to New Heights in 2023 ↗

May 01, 2023

Here are three stocks to buy, for investors looking for companies on the cusp of a potential breakout driven by secular growth catalysts.

Via InvestorPlace

If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today ↗

April 27, 2023

Via Benzinga

Why Abbott Laboratories Stock Looks Ridiculously Overpriced ↗

April 27, 2023

Abbott's stock is trading at a huge premium, and it isn't a justifiable one for investors.

Via The Motley Fool

Can Boston Scientific Set Another Net High?

April 27, 2023

Boston Scientific issued a stellar report and gave favorable guidance, but the stock is having difficulty moving higher and may move sideways in the near term.

Via MarketBeat

Is Abbott Laboratories Stock a Buy for Dividend Investors? ↗

April 25, 2023

This healthcare company stands out among its peers as a Dividend King.

Via The Motley Fool

Abbott Laboratories Unusual Options Activity ↗

April 21, 2023

Via Benzinga

P/E Ratio Insights for Abbott Laboratories ↗

April 21, 2023

Via Benzinga

7 Healthcare Stocks With Huge Return Potential for Long-Term Investors ↗

April 27, 2023

These leading healthcare companies have proven that they can deliver reliable gains to their shareholders over many years and decades.

Via InvestorPlace

The Fed Predicts a Recession: Should You Still Buy Stocks Now? ↗

April 25, 2023

The Fed expects a "mild" downturn.

Via The Motley Fool

Sleep Easy With These 2 Rock-Solid Dividend Stocks ↗

April 25, 2023

They aren't in any danger of crimping their dividends.

Via The Motley Fool

This Supercharged Dividend King Stock Might Soon Run Out of Steam ↗

April 25, 2023

Emerging competitive threats in immunology, oncology, and medical aesthetics, along with a highly leveraged balance sheet, might dampen the drugmaker's growth trajectory post-2025.

Via The Motley Fool

This Company's Non-Invasive Tech Looks To Be Unique In the Market And Can Help People Take Ownership Over Monitoring Their Health ↗

April 25, 2023

The need for noninvasive healthcare technology that allows people to take ownership and gather more insight into their health became acute when COVID revealed the fragility of the hospital system.

Via Benzinga

Is Abbott Laboratories Still a Good Dividend Stock to Buy? ↗

April 23, 2023

A better-than-expected first-quarter report already pushed it much higher.

Via The Motley Fool

Stock Market Rally Drifts Lower; Tesla Dives On Margins; ISRG, DHI, LVS Are Winners: Weekly Review ↗

April 21, 2023

The major indexes saw modest declines, holding in a range.

Via Investor's Business Daily

Healthcare Sector Update: MedTech Trending Up ↗

April 20, 2023

Earnings from major device companies and large-cap biopharma over the next two weeks will help us ascertain risks for the market.

Via Talk Markets

Abbott Laboratories To Rally 17%? Here Are 10 Other Analyst Forecasts For Thursday ↗

April 20, 2023

Morgan Stanley cut the price target for Charter Communications, Inc. (NASDAQ: CHTR) from $460 to $420. Morgan Stanley analyst Benjamin Swinburne maintained an Equal-Weight rating. Charter...

Via Benzinga

CBOE Volatility Index Drops To Lowest Level Since November 2021; S&P 500 Ends Almost Flat ↗

April 20, 2023

The S&P 500 closed almost flat on Wednesday following the release of corporate earnings.

Via Benzinga

Tesla, Rivian, IBM, Zions, Lam Research: Why These Five Stocks Are Drawing Investors' Attention Today ↗

April 19, 2023

Via Benzinga

Why Medtronic Stock Soared More Than 4% Higher Today ↗

April 19, 2023

The veteran device maker did well on a very good day for stocks in its industry.

Via The Motley Fool

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

50 51 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Abbott Laboratories (NY:ABT)

All News about Abbott Laboratories

Starting at $3.75/week.

Subscribe Today